Yüklüyor......
Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
This double-blind placebo-controlled, fixed/flexible-dose phase 2 trial assessed the efficacy, safety, and tolerability of cariprazine vs. placebo for depressive episodes associated with bipolar I or II disorder. Primary endpoint was change in Montgomery–Åsberg Depression Rating Scale (MADRS) total...
Kaydedildi:
| Yayımlandı: | Int Clin Psychopharmacol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams And Wilkins
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7099842/ https://ncbi.nlm.nih.gov/pubmed/32058426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000307 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|